GroundTruth Project/GlobalPost: In Ebola response, Big Pharma and public sector strive to make up for lost time
“…The delayed response [to Ebola] is an example of the diverging interests of public and private sectors when it comes to addressing a public health crisis, say experts from both sides. … Still, some experts question whether the public-private partnership model will be successful in making a vaccine available to the poorest populations. They caution that when private companies get involved in public health, profit motives could dictate who ultimately benefits from the drugs…” (Murray, 1/29).